A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Neoplasms, Breast
Interventions: DRUG: Doxorubicin|DRUG: Pazopanib (GW786034)|DRUG: Epirubicin
Sponsor: GlaxoSmithKline